Truking Technology's 2021 mid-year report released, overall revenue increased by 72.75%, bioengineering business developing rapidly
2021-11-12 14:59
Truking Technology's 2021 Semi-Annual Report was released on August 27, showing significant increases in multiple indicators such as revenue and net profit. The operating income for the first half of the year reached 2.391 billion yuan, a year-on-year increase of 72.75%; net profit attributable to shareholders of the listed company was 236 million yuan, a year-on-year increase of 1321.22%. Among the many product segments supporting the business performance, the inspection and packaging solutions and standalone machine business were particularly outstanding, with revenue reaching 830 million yuan, a year-on-year increase of 135.42%. The bioengineering solutions and standalone machine business segment also developed rapidly, with revenue increasing by 255.41% year-on-year. R&D investment continued to steadily rise, nearly 200 million yuan, a year-on-year increase of 65.65%. Although the overseas market was affected by the uncertainties of the COVID-19 pandemic, Truking Technology also performed well in several overseas regions in the first half of 2021, such as Europe with revenue growth of 11.27% and the Americas with revenue growth of 74.67%.
The significant improvement in Truking Technology's business performance stems from the active implementation and promotion of its strategy. The company continuously enhances its market and marketing capabilities, strengthens internal operational management, and fully leverages the synergy among its subsidiaries. New orders in the first half of 2021 increased by 136% year-on-year. Based on this, Truking Technology continuously improved its product manufacturing, delivery, and commissioning capabilities, with product deliveries significantly increasing compared to the same period last year. Continuous increased investment in R&D of new technologies and new products is also an important driver of performance growth. Truking Technology's product structure and configuration are continuously optimized, with ongoing improvements in product technology and quality. Meanwhile, Truking Technology has also achieved important results in internal cost control and supply chain optimization.
Driven by both intrinsic growth and external expansion, Truking Technology is currently the only company in the industry capable of supplying both overall solutions for liquid formulations and solid formulations, possessing many highly competitive product portfolios. Product upgrades and new product development have also continuously yielded results, with the rapid growth of Truking Technology's bioengineering business in the first half of the year being one such achievement. Currently, Truking Technology has formed related solutions and products in the bioprocess front end, including stainless steel reaction fermentation systems, chromatography separation and purification systems, and preparation systems. It has also completed layouts for some key customers and is actively planning the development of single-use bioreactors and related consumables for the bioprocess front end to continuously improve the product chain.
The development of product layout and increased R&D investment have also led to an expansion in the scale of R&D personnel. In the first half of 2021, Truking Technology's R&D staff exceeded 1,500. Truking Technology adheres to the "dual priority" strategy of product technology and manufacturing technology, continuously improving manufacturing and processing capabilities, especially steadily enhancing the processing technology and level of core components, further promoting product quality improvement. Its subsidiary Truking Huaxing has continuously expanded its business scale, and its excellent precision manufacturing capabilities have undertaken important processing tasks for Truking Technology. The integration of Romaco Group's German manufacturing philosophy has also continuously improved Truking Technology's manufacturing level. With the steady progress of the Phase IV project construction, the company's production capacity is also continuously increasing.
While achieving good growth in business performance, Truking Technology is also actively fulfilling its social responsibilities, especially playing an indispensable and important role in the fight against the COVID-19 pandemic. In response to the national call to scale up COVID-19 vaccine production and ensure vaccine supply, Truking Technology efficiently mobilized its technical R&D, manufacturing, and after-sales service capabilities, working day and night to develop core equipment for large-scale COVID-19 vaccine production, including washing, drying, filling, and sealing linked production lines, intelligent inspection equipment, and post-packaging production lines. This fully ensured the production of important Chinese COVID-19 vaccine companies such as China National Pharmaceutical Group, Sinovac, CanSino, and Zhifei Longcom, making a significant contribution to China's COVID-19 vaccine supply.
Contact Us
Address: National Ningxiang Economic and Technological Development Zone Chutian Technology Industrial Park, China